PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
The next chapter of clinical trial services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
BIO-Europe 2023: Pharma balances on shaky financial and legislative footing
FT Summit: AI and regulatory changes at the forefront of industry’s mind
Childproof packaging: How things are changing for consumer drugs
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
Xphozah wins orphan drug designation for paediatric hyperphosphatemia
Certa plans pivotal scleroderma trial after Phase II data readout
UK MHRA extends licence for Vertex’s children’s cystic fibrosis drugs
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Certa plans pivotal scleroderma trial after Phase II data readout
Astellas to take over Propella Therapeutics for $175m
Signal: Pfizer cuts 500 UK jobs in restructuring after posting Q3 loss
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Signal: Pfizer cuts 500 UK jobs in restructuring after posting Q3 loss
Signal: Wegovy cuts cardiovascular risk by 20% for heart disease patients
AstraZeneca posts 16% drop in Q3 2023 profit after tax
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
A new era for pMDI propellants
Evaluating the top five sterilisation techniques for parenteral packaging
Analytical testing: Ten questions that accelerate drug development
Events
Reports
Premium Insights
Newsletters
PT
All articles by Sophie Cairns
Sophie Cairns
Analyst Comment
China’s latest NRDL update continues to exclude foreign PD-1 inhibitors, favours rare disease drugs
Analyst Comment
Delytact: The world’s first oncolytic virotherapy for brain cancer
Analyst Comment
Japan’s new CEA-based price adjustments set to maintain pricing pressure on innovative drugs
Analyst Comment
China’s young biosimilars sector
Analyst Comment
South Korean pharma dreams struggle
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
Analyst Comment
Inconsistent application of pricing policies in China contributes to pockets of high prices
Analyst Comment
HTA adoption in Asian emerging pharma markets
Analyst Comment
Regulatory convergence or divergence for Asian pharma
Analyst Comment
Culture shift at Takeda a sign of things to come
Analyst Comment
US tariffs likely to mostly affect US generics makers
View more
Most Popular
Japan approves Daiichi Sankyo’s Covid-19 booster vaccine
FDA grants orphan drug status for Arcturus’ cystic fibrosis therapy
Signal: British biopharma applies for BLA for T-cell cancer therapy
